Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ally Financial
ALLY
5
Bank of America
BAC
US OptionsDetailed Quotes
PFE250516P32000
- 9.54
- 0.000.00%
15min DelayClose May 14 16:00 ET
0.00High0.00Low
9.54Open9.54Pre Close0 Volume0 Open Interest32.00Strike Price0.00Turnover266.20%IV-2.00%PremiumMay 16, 2025Expiry Date9.98Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9819Delta0.0122Gamma2.20Leverage Ratio-0.0200Theta-0.0009Rho-2.16Eff Leverage0.0006Vega
Pfizer Newsroom
Trump's drastic cuts to drug prices may cause a reshuffle in the pharmaceutical industry. After examining policy risks, Citigroup remains firmly Call on Regeneron (REGN.US).
This rating adjustment comes right after an executive order signed by USA President Donald Trump on Monday local time.
Express News | Pfizer Files Pricing Term Sheet for Four-Part Euro-Denominated €3.3 Bln Notes Offering - SEC Filing
Pfizer Inc. Stock Falls 3.7%, Underperforms Market
Pfizer Options Spot-On: On May 14th, 189.89K Contracts Were Traded, With 3.45 Million Open Interest
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Fund Update: ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Opened a $330.9M Position in $PFE Stock
Jim Cramer on Pfizer (PFE) – "Caught in a Vortex, but I'm Sticking With Seagen and Dr. Bourla"
Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck. -- Barrons.com
Pfizer Subsidiary Receives A2 Rating From Moody's With Stable Outlook
The European Court made an unfavorable ruling on the "Pfizer Gate" incident, and von der Leyen faces a political challenge.
① The General Court of the European Union believes that the action of the European Commission in "not finding" and deeming it unnecessary to search for private communication information between Von der Leyen and the CEO of Pfizer is illegal; ② The European Commission issued a statement saying it will carefully study the court's ruling and decide on the next steps.
EU Court Annuls Commission's Decision to Deny Access to Pfizer Texts With Von Der Leyen
Today's Analyst Rating | NVIDIA Price Target Raised to $160 by BofA Securities, KeyBanc Cuts Its Price Target Cut on UnitedHealth to $450
Citi Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $25
Pfizer (PFE.US) issues Euro Bonds for the first time in seven years, contributing to the hot trend of reverse Yankee bond issuance.
Pfizer (PFE.US) issued Euro Bonds for the first time in seven years, joining the recent surge in reverse Yankee bond issuance.
Express News | EU: Commission Will Adopt a New Decision Providing a More Detailed Explanation Following Court Decision on Pfizer Vaccine Messages
Pfizer Returns to Euro Market Joining Record Spree of US Issuers
Express News | EU Court Backs New York Times in Fight With EU Commission Over Pfizer Vaccine Messages
Express News | Pfizer Dissolves Share Stake in Akero Therapeutics- SEC Filing
Pfizer Options Spot-On: On May 13th, 100.17K Contracts Were Traded, With 3.43 Million Open Interest
Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump's Executive Order. -- Barrons.com
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
